-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Immuneonco Biopharmaceuticals (Shanghai) Receives FDA Approval For IND Application Of IMM0306 For Phase IB/II SLE Trial

路透·08/21/2026 15:44:22

登录查看新闻详情